ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma
2022 · Cell Death Discovery · 93 citations
https://doi.org/10.1038/s41420-022-01286-w
H
Huijun Zeng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
809
Citations
15
h-index
16
i10-index
Huijun Zeng is an academic researcher from Zhujiang Hospital. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 15, co-authored 21 publications.
ORCID: 0000-0001-5785-5294Papers by this author
worksConnective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
2017 · Cell Death and Disease · 53 citations
https://doi.org/10.1038/cddis.2017.248
<scp>STAT</scp>3 promotes tumour progression in glioma by inducing <scp>FOXP</scp>1 transcription
2018 · Journal of Cellular and Molecular Medicine · 27 citations
https://doi.org/10.1111/jcmm.13837
Associations Between Family Function and Non-suicidal Self-injury Among Chinese Urban Adolescents with and Without Parental Migration
2023 · Child Psychiatry & Human Development · 27 citations
https://doi.org/10.1007/s10578-023-01528-7
ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma
2025 · Cancer Letters · 5 citations
https://doi.org/10.1016/j.canlet.2025.217439
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat